Management of Low-Risk Papillary Thyroid Cancer

다국어 초록 (Multilingual Abstract)

The incidence of thyroid cancer has increased, mainly due to the incidental finding of low-risk papillary thyroid cancers (PTC). These malignancies grow slowly, and are unlikely to cause morbidity and mortality. New understanding about the prognosis of tumor features has led to reclassification of many tumors within the low-risk thyroid category, and to the development of a new one “very low-risk tumors.” Alternative less aggressive approaches to therapy are now available including active surveillance and minimally invasive interventions. In this narrative review, we have summarized the available evidence for the management of low-risk PTC.

참고문헌 (Reference)

1 Vaccarella S, "Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis" 375 : 614-617, 2016

2 Guth S, "Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination" 39 : 699-706, 2009

3 Tuttle RM, "Updated American Joint Committee on cancer/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why?" 27 : 751-756, 2017

4 Radzina M, "Update on the role of ultrasound guided radiofrequency ablation for thyroid nodule treatment" 41 (41): S82-S93, 2017

5 Zhou W, "Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: preliminary results" 27 : 2934-2940, 2017

6 Valcavi R, "Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation" 23 : 1578-1582, 2013

7 Hay ID, "Ultrasound-guided percutaneous ethanol ablation for selected patients with papillary thyroid microcarcinoma: a novel, effective and well tolerated alternative to neck surgery or observation" 2017

8 Papini E, "Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk" 21 : 917-920, 2011

9 Cheng Z, "US-guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: a prospective multicenter study" 7 : 9554-, 2017

10 Gazelle GS, "Tumor ablation with radio-frequency energy" 217 : 633-646, 2000

11 Dionigi G, "Transoral endoscopic thyroidectomy via a vestibular approach: why and how?" 59 : 275-279, 2018

12 Nixon IJ, "Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy" 151 : 571-579, 2012

13 Matsuzu K, "Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases" 38 : 68-79, 2014

14 Sugitani I, "Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes" 34 : 1222-1231, 2010

15 Dal Maso L, "The impact of overdiagnosis on thyroid cancer epidemic in Italy, 1998-2012" 94 : 6-15, 2018

16 Nixon IJ, "The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer" 150 : 1242-1249, 2011

17 Vaccarella S, "The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries" 25 : 1127-1136, 2015

18 Lloyd RV, "The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)" 74 : 1-4, 2018

19 Sacks W, "The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008" 20 : 1235-1245, 2010

20 American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer" 19 : 1167-1214, 2009

21 Jeong SY, "Radiofrequency ablation of primary thyroid carcinoma: efficacy according to the types of thyroid carcinoma" 2018

22 Cervelli R, "Radiofrequency ablation in the treatment of benign thyroid nodules: an efficient and safe alternative to surgery" 28 : 1400-1408, 2017

23 Cesareo R, "Radiofrequency ablation for the management of thyroid nodules: a critical appraisal of the literature" 87 : 639-648, 2017

24 Dean DS, "Prognostic indicators in differentiated thyroid carcinoma" 7 : 229-239, 2000

25 Ito Y, "Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up" 36 : 1274-1278, 2012

26 Hay ID, "Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1,779 patients surgically treated at one institution during 1940 through 1989" 114 : 1050-1057, 1993

27 Youngwirth LM, "Patients treated at low-volume centers have higher rates of incomplete resection and compromised outcomes: analysis of 31,129 patients with papillary thyroid cancer" 23 : 403-409, 2016

28 Ito Y, "Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation" 24 : 27-34, 2014

29 Jianyi Sun, "Papillary Thyroid Carcinoma Treated with Radiofrequency Ablation in a Patient with Hypertrophic Cardiomyopathy: A Case Report" 대한영상의학회 17 (17): 558-561, 2016

30 Xu B, "Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features" 27 : 512-517, 2017

31 Xu B, "Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: historical context, diagnosis, and future challenges" 28 : 128-138, 2017

32 Nikiforov YE, "Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors" 2 : 1023-1029, 2016

33 Thompson LD, "Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment" 29 : 698-707, 2016

34 Tuttle RM, "Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance" 143 : 1015-1020, 2017

35 Hay ID, "Minimal extrathyroid extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative tumor recurrence" 159 : 11-19, 2016

36 Zhao Q, "Meta-analysis of radiofrequency ablation for treating the local recurrence of thyroid cancers" 39 : 909-916, 2016

37 Hay ID, "Management of patients with low-risk papillary thyroid carcinoma" 13 : 521-533, 2007

38 Mancino AT, "Management of differentiated thyroid cancer" Springer 205-222, 2017

39 Lamartina L, "Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature" 100 : 1748-1761, 2015

40 Adam MA, "Is there a minimum number of thyroidectomies a surgeon should perform to optimize patient outcomes" 265 : 402-407, 2017

41 Miyauchi A, "Insights into the management of papillary microcarcinoma of the thyroid" 28 : 23-31, 2018

42 Arora N, "Extrathyroidal extension is not all equal: implications of macroscopic versus microscopic extent in papillary thyroid carcinoma" 144 : 942-947, 2008

43 Zhang M, "Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study" 26 : 1581-1587, 2016

44 Davies L, "Current thyroid cancer trends in the United States" 140 : 317-322, 2014

45 Tarasova VD, "Current management of low risk differentiated thyroid cancer and papillary microcarcinoma" 29 : 290-297, 2017

46 Jin BJ, "Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma" 51 : 759-763, 2015

47 Hodak S, "Changing the cancer diagnosis: the case of follicular variant of papillary thyroid cancer-primum non nocere and NIFTP" 26 : 869-871, 2016

48 Al-Qurayshi Z, "Association of surgeon volume with outcomes and cost savings following thyroidectomy: a national forecast" 142 : 32-39, 2016

49 Ito Y, "An observational trial for papillary thyroid microcarcinoma in Japanese patients" 34 : 28-35, 2010

50 Ito Y, "An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid" 13 : 381-387, 2003

51 Davies L, "American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: the increasing incidence of thyroid cancer" 21 : 686-696, 2015

52 Janovsky CC, "A prospective study showing an excellent response of patients with low-risk differentiated thyroid cancer who did not undergo radioiodine remnant ablation after total thyroidectomy" 5 : 44-49, 2016

53 Farkas EA, "A comparison of total thyroidectomy and lobectomy in the treatment of dominant thyroid nodules" 68 : 678-682, 2002

54 Brito JP, "A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma" 26 : 144-149, 2016

55 Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer" 26 : 1-133, 2016